OPENING OF BANKRUPTCY

DALE Pharma

Company — Opening of bankruptcy.

Financial year 2023 · Closed on 31/12/2023

Net result
716 €
Revenue
3,3 M €
Equity
606 k €
Workforce
17,6 ETP

Identity

Source · BCE/KBO

DALE Pharma is a Private limited company incorporated in 2022. Its main activity is: Retail sale in non-specialised stores. Its registered office is in Enghien. It employs on average 17,6 ETP workers (FTE).

Legal situation
Opening of bankruptcy
BCE/KBO no. / VAT
BE 0791.839.803
Incorporation
04/10/2022
Legal form
Private limited company
Registered office
Grand Place(E) 50
7850 Enghien · WallonieSee on map
Contributed capital
605 297,00 €
Latest accounts
31/12/2023
Average workforce
17,6 ETP
Contacts
2 public details availableLog in to view
Signals
ProfitableGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 1 filing

Trend over 1 financial year

2023
Income statement
Revenue3,3 M €
EBITDA94,6 k €
Operating result44,2 k €
Net result716 €
Balance sheet
Equity606 k €
Total assets3,1 M €
Cash33,6 k €
Debts2,5 M €
Other
Workforce17,6 ETP

Board of directors

Source · NBB, accounts to 31/12/2023

1 active

Active mandates

Didier Petre

Mandate

Active

Other companies at this address

Grand Place(E) 50 7850 Enghien
CompanyCBE no.
AG-fix-IT● Active
0776.507.269
1027.047.183
BYGHY CONSTRUCT● Bankrupt
0670.495.474
EGOMATIC● Active
0837.724.464
FEEL I.T.● Active
0476.743.716
FIGRA● Active
0890.248.281
MG Vision● Active
1030.950.939
NJ-INNOVATION● Active
1001.721.968
1026.636.716
PROJET DRISHTI● Active
1038.875.542
SynergyWorks● Active
1016.572.272
The Mug Enghien● Active
0676.565.595
V2v CONSTRUCT● Liquidation
0790.569.893

Full financial information

Source · NBB
2023
Type of accountAbridged model
Start of the financial year01/10/2022
Closing of the financial year31/12/2023
Length of the financial year15 months
Filing date15/08/2024
General meeting15/06/2024
Currency of the financial yearEUR
NBB quality labelSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 1 filing
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202315/06/202415/08/2024FrenchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2023

1 active

Active mandates

Didier Petre

Mandate

Active

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office12/09/2024
    SIEGE SOCIAL
    PDF
  • Mandates08/03/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Other22/02/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Capital / shares01/08/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Registered office14/03/2023
    SIEGE SOCIAL
    PDF
  • Mandates22/02/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Other06/10/2022
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2023
    Annual accounts 2023716 €
  2. 04/10/2022
    IncorporationPrivate limited company